US EditionPublished • loading... • Updated
Annovis Bio Publishes Data on New Crystal Form of Lead Alzheimer’s Drug
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Annovis Bio Publishes Data on New Crystal Form of Lead Alzheimer’s Drug
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the publication of a peer-reviewed article in Biomolecules detailing the pharmacokinetic profile of a newly developed crystal form of buntanetap, its lead Alzheimer’s candidate. The study compared the new dihydrate crystal to the original anhydrous form across animal and human trials. The findings confirmed that the crystal form preserves the absorption, metabolism, and clearance properties …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
